Bioverge

The Bioverge Podcast
  • 4.9 (10)
  • ECONOMÍA Y EMPRESA
Bioverge

Join Neil Littman on The Bioverge Podcast as he explores the intersection of bio x tech and features the entrepreneurs, investors, and industry leaders who are revolutionizing healthcare and bringing science fiction to life.

  1. Decoding Biotech: A Deep Dive into AI and Platform Technologies

    1 ENE

    Decoding Biotech: A Deep Dive into AI and Platform Technologies

    Kiersten Stead, Co-Founder and Managing Partner of DCVC Bio sits down with Neil to discuss her firm’s approach to deep tech investing in biotech, her focus on platform technologies, and how to separate what’s real from what’s hype in AI

    49 min
  2. Financing Biotech: Portfolio Theory and Netflix-Inspired Models

    01/12/2023

    Financing Biotech: Portfolio Theory and Netflix-Inspired Models

    Andrew Lo, Professor of Finance, and the Director of the Laboratory for Financial Engineering at the MIT Sloan School of Management, sits down with Neil to discuss his application of portfolio theory to address the challenges of funding drug development and how a Netflix subscription model can address the coming crisis in funding high-priced curative therapies approaching the market.

    1 h y 5 min
  3. Bringing A Hub-and-Spoke Business Model to Regenerative Medicine

    01/11/2023

    Bringing A Hub-and-Spoke Business Model to Regenerative Medicine

    Faizzan Ahmad, Co-Founder and CEO of Cure8bio, sits down with Neil to discuss its growing portfolio of regenerative medicines in development, its hub-and-spoke business model designed to leverage resources and reduce risk, and its push toward curative therapies.

    45 min
  4. Enlisting Liquid Biopsies in the Fight Against Chronic Diseases

    01/10/2023

    Enlisting Liquid Biopsies in the Fight Against Chronic Diseases

    Nathan Hunkapiller, Chief Scientific Officer and Co-Founder of Curve Biosciences, sits down with Neil to discuss liquid biopsies, the company’s efforts to expand the use of these blood-based tests to improve the treatment of chronic diseases, and how it is enabling earlier intervention.

    57 min
  5. Developing Targeted Therapies to Address Heart Failure

    01/09/2023

    Developing Targeted Therapies to Address Heart Failure

    Drew Titmarsh, Co-Founder and CEO of Dynomics, sits down with Neil to discuss that lack of innovative therapies to treat heat disease, the company’s discovery platform that uses engineered cardiac organoids that function like adult human heart tissue, and how the company is using this to develop precision therapies to address the root causes of heart failure.

    46 min
  6. Speeding Drug Development by Unlocking the Mechanism of Action of Cancer Therapies

    15/08/2023

    Speeding Drug Development by Unlocking the Mechanism of Action of Cancer Therapies

    David Li, Co-Founder and CEO of Meliora Therapeutics, sits down with Neil to discuss why the mechanism of action for cancer therapies in development is poorly understood, how this leads to a high and costly clinical failure rate, and how Meliora's platform technology uncovers the true mechanism of action of a drug and it enables it to identify promising drug scaffolds to accelerate the development process.

    50 min
  7. Enlisting the Viral Immune System in the Fight Against Cancer

    01/06/2023

    Enlisting the Viral Immune System in the Fight Against Cancer

    Anat Burkovitz, CEO of TrojanBio, sits down with Neil to discuss its AI-drive antibodies platform, how it enlists the viral immune system in the fight against cancer, and why she thinks the technology will broaden the population of patients who will benefit from immunotherapies.

    40 min
  8. Bringing Precision Medicine to Psychiatry

    22/05/2023

    Bringing Precision Medicine to Psychiatry

    Amit Etkin, Founder and CEO of Alto Neuroscience, sits down with Neil to discuss the lack of innovation in psychiatric medicines, how the company has identified AI-derived brain biomarkers, and how that is fueling its pipeline of precision therapies to treat mental health disorders.

    55 min
Ver todo (43)

Calificaciones y reseñas

4.9
de 5
10 calificaciones

Acerca de

Join Neil Littman on The Bioverge Podcast as he explores the intersection of bio x tech and features the entrepreneurs, investors, and industry leaders who are revolutionizing healthcare and bringing science fiction to life.

Información

  • Creador
    The Bioverge Podcast
  • Años de actividad
    2021 - 2024
  • Episodios
    43
  • Clasificación
    Apto
  • Copyright
    © All rights reserved
  • Mostrar sitio web
    Bioverge

Para escuchar episodios explícitos, inicia sesión.

Mantente al día con este programa

Inicia sesión o regístrate para seguir programas, guardar episodios y enterarte de las últimas novedades.
Elige un país o región

Africa, Oriente Medio e India

Asia-Pacífico

Europa

Latinoamérica y el Caribe

Estados Unidos y Canadá